NVUS News and Press, Novus Therapeutics Inc. From 11/02/20

Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS), a clinical stage biopharmaceutical company focused on developing life-changing, targeted medicines for patients undergoing organ or cellular transplantation, as well as those living with immunological diseases, today annou...

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. Stocks fell on Friday, led by the megacap tech names, to wrap up the worst week since March as coronavirus cases surged, U.S. fiscal stimulus...

Gainers: Universal Security Instruments (UUU) +69%.Polar Power (POLA) +37%.Rekor Systems (REKR) +35%.Entercom Communications (ETM) +33%.Pinterest (PINS) +29%.Inphi (IPHI) +28%.Forte Biosciences (FBRX) +21%.Meta Financial Group (CASH) +19%.Novus Therapeutics (NVUS) +18%.Dig...

Gainers: Kiniksa Pharmaceuticals (KNSA) +18%, Humanigen (HGEN) +15%, Neuronetics (STIM) +16%, American Well (AMWL) +13%, Xtant Medical (XTNT) +5%.Losers: Corbus Pharmaceuticals (CRBP) -39%, Axovant Gene Therapies (AXGT)-20%, Iovance Bioth...

Gainers: MyoKardia (MYOK) +58%, Eidos Therapeutics (EIDX) +41%, Enlivex Therapeutics (ENLV) +25%, Humanigen (HGEN) +28%, Corvus Pharmaceuticals (CRVS) +26%.Losers: Xtant Medical Holdings (XTNT) -15%, Curis (CRIS) -7%, Immunome (...

Novus Therapeutics ([[NVUS]] -6.6%) announced a reverse stock split of its issued and outstanding common stock, at a ratio of 1-for-18, effective 12:01 a.m. (Eastern Time) on October 5, 2020.Shares to trade on a split-adjusted basis commencing upon market open on October 5, 2020. For furthe...

Novus Therapeutics, Inc. (NASDAQ : NVUS) today announced that it has filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation to effect a reverse stock split of its issued and outstanding common stock, at a ratio of 1-for-18. The effective time of the re...

Are These On Your List Of Robinhood Penny Stocks To Buy Right Now? There’s no doubt about it, trading penny stocks on Robinhood has become almost a right of passage for new traders. There were quite literally millions of new accounts opened on the platform this year. Thanks t...

Arbutus reports positive data for AB-729 for chronic hepatitis B. Marinus Pharmaceuticals hits primary endpoint in the Genetic Epilepsy trial. Novus Therapeutics on upswing on Anelixis acquisition. For further details see: Arbutus Reports Positive Hepatitis B Data, And O...

Strongbridge Biopharma (NASDAQ: SBBP )   -16%  after pricing $25M share offering. More news on: Strongbridge Biopharma plc, NuCana plc, Dave & Buster's Entertainment, Inc., Stocks on the move, , Read more ...